Diabetes Mellitus
2 competing products in clinical development for Diabetes Mellitus.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pioglitazone + Rosiglitazone | Eli Lilly | Phase 3 | Completed | 77 |
| placebo + exenatide | Eli Lilly | Phase 2 | Terminated | 52 |